Author

Aristeidis Sionakidis

Observed names: A. Sionakidis, Aris Sionakidis, Sionakidis, Aristeidis

Institutions: University of Cambridge, Cancer Research UK Cambridge Center

Observed institutions: University of Cambridge, Cancer Research UK Cambridge Center, Institute of Genetics and Cancer, University of Edinburgh

ORCID: 0000-0003-0814-9478

Observed ORCID: 0000-0003-0814-9478

OpenAlex ID: A5065366105

Survey and Evaluation of Hypertension Machine Learning Research

2023 · Clea du Toit, Tran Quoc Bao Tran, et al. · Journal of the American Heart Association · 20

Unravelling the tangled web of hypertension and cancer

2021 · Aristeidis Sionakidis, Linsay McCallum, et al. · Clinical Science · 19

Investigating the Quality of Machine Learning Research and Reporting in Hypertension

2022 · Clea Du Toit, Tran Tran, et al. · Journal of Hypertension · 2

Tumour region identification guided scoring (TRIGS) and foundation model-based Tumour Infiltrating Lymphocyte scoring are prognostic for pathological complete response/event free survival in the triple negative patients in the PARTNER randomized controlled trial

2026 · Philip C. Schouten, Melis O. Irfan, et al. · medRxiv

Protocol for detecting causal variants by co-localizing GWAS and QTL studies using colocRedRibbon

2026 · Theodora Papadopoulou, Aristeidis Sionakidis, et al. · STAR Protocols

Consensus Through Diversity: A Comprehensive Benchmark of Multi-Omic Approaches for Precision Breast Oncology

2026 · Aristeidis Sionakidis, Karen Pinilla Alba, et al. · bioRxiv (Cold Spring Harbor Laboratory)

315P SYNERGIA breast cancer: Automated assessment of tumour-infiltrating lymphocytes

2025 · P. Schouten, M. Irfan, et al. · Annals of Oncology

Abstract LB339: SYNERGIA Breast Cancer - Revolutionizing breast cancer care with multi-modal data integration for personalised treatment and future trials

2025 · Amy Riddell, Joanna R. Worley, et al. · Cancer Research

Identification of diagnostic markers of pancreatic ductal adenocarcinoma using transcriptomic tumour and blood sample data

2023 · Aristeidis Sionakidis, Panagiotis Nikolaos Lalagkas, et al. · Clinical and Translational Discovery

A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patients

2023 · Aristeidis Sionakidis, Timothy I. Cannings, et al. · Research Square

Identification of early diagnosis markers of pancreatic ductal adenocarcinoma (PDAC) using publicly available transcriptomic tumor and blood sample data

2022 · Aristeidis Sionakidis, Panagiotis Nikolaos Lalagkas, et al. · Research Square

Identification of early diagnosis markers of pancreatic ductal adenocarcinoma (PDAC) using publicly available transcriptomic tumour and blood sample data

2022 · Aristeidis Sionakidis, Panagiotis Nikolaos Lalagkas, et al. · Research Square

Abstract 1233: A novel 14-gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in breast cancer patients

2022 · Aristeidis Sionakidis, Jonine D. Figueroa, et al. · Cancer Research

Works count: 14

Citation count: 41

H-index: 2

I10-index: 2